Home » GI Dynamics Gets FDA Conditional OK for a Trial of its EndoBarrier Obesity Treatment
GI Dynamics Gets FDA Conditional OK for a Trial of its EndoBarrier Obesity Treatment
GI Dynamics announced it has received conditional approval from the FDA to start a pivotal clinical trial of its EndoBarrier device for the treatment of patients who have uncontrolled Type 2 diabetes and who are obese.
Boston Globe
Boston Globe
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May